| MINI SUMMARY · Everything on this page in fourteen lines • Cytokines are short range chemical messages. Interleukins are the subset that immune cells send to each other. • IL 1, IL 6 and TNF alpha are the three pyrogens. They cause fever and acute phase reactants. • IL 2 is the T cell growth factor. It expands helper, cytotoxic and regulatory T cells. • IL 3 behaves like GM CSF and supports bone marrow stem cells. • IL 4 drives Th2 differentiation and class switching to IgE. • IL 5 drives eosinophils and class switching to IgA. • IL 8 is the neutrophil chemoattractant. • IL 10 and TGF beta are the anti inflammatory pair released by Treg cells. • IL 12 drives Th1 differentiation. Its receptor deficiency causes disseminated mycobacterial infection. • IL 17 and IL 22 come from Th17 cells and defend the epithelial barrier. • IL 23 maintains Th17 cells once IL 6 and TGF beta have created them. • IFN gamma is the macrophage activator. TNF alpha maintains the granuloma. • Every major biologic drug blocks one named cytokine, so the drug tells you the pathway. • Th1 fights inside the cell, Th2 fights what is too big to eat, Th17 guards the surfaces, Treg switches it off. |
Cytokines are examined more heavily than almost any other immunology subtopic, and the reason is structural rather than biological. A cytokine sits at the junction of four disciplines at once, so a single question can test immunology, pathology, microbiology and pharmacology together. That is exactly what the current integrated blueprint rewards.
Expect between three and six cytokine dependent items on a typical form. Many of them will not be labelled as immunology at all.
The table below shows how the same fact reappears across the examination under four different disguises.
| Discipline | How cytokines appear | The link you must be able to state |
|---|---|---|
| Pathology | Acute inflammation and the acute phase response | IL 1, IL 6 and TNF alpha raise CRP, fibrinogen, ferritin and hepcidin |
| Microbiology | Tuberculosis and disseminated mycobacterial disease | IL 12 drives Th1, Th1 makes IFN gamma, IFN gamma activates macrophages |
| Pharmacology | Biologic therapy | Every monoclonal antibody names its own target, so the drug reveals the pathway |
| Haematology | Anaemia of chronic disease | IL 6 raises hepcidin, which traps iron in macrophages |
| Allergy | Asthma and atopic disease | IL 4, IL 5 and IL 13 are the Th2 trio behind IgE and eosinophils |
| Rheumatology | Rheumatoid arthritis, psoriasis, spondyloarthritis | TNF alpha, IL 6, IL 17 and IL 23 are the four druggable targets |
| Critical care | Sepsis and cytokine release syndrome | TNF alpha and IL 6 drive the vascular leak and the hypotension |
Cytokines are not the only topic that behaves this way. Our breakdown of which Step 1 topics carry the most question weight shows where else one concept pays out across several subjects.
| HOW WE TEACH THIS · Why we teach cytokines early We place cytokines near the front of the Ultimate Integrated Teaching immunology block rather than at the end. The reason is leverage. Once a student owns the cytokine map, tuberculosis, asthma, psoriasis, rheumatoid arthritis and sepsis all become variations on a diagram they already have. Teaching it late means teaching each of those diseases twice. |
| CLINICAL PEARL · Case vignette A 14 month old boy is admitted with fever, weight loss and enlarged cervical lymph nodes. Culture of a node grows Mycobacterium avium complex. He had a disseminated infection after routine BCG vaccination at three months of age. He has also had one episode of non typhoidal Salmonella bacteraemia. Neutrophil count, immunoglobulin levels, complement studies and the nitroblue tetrazolium test are all normal. His parents are first cousins. |
Stop and reason before reading on. Four features narrow this to a single molecule.
Intracellular organisms are killed by activated macrophages. Macrophages are activated by IFN gamma. IFN gamma comes from Th1 cells. Th1 cells are created by IL 12. This child almost certainly has an IL 12 receptor deficiency, and the confirmatory finding will be a low IFN gamma level.
| EXAM TRAP · The trap in this stem Students who half know this topic answer chronic granulomatous disease, because both conditions give recurrent infection with organisms that live inside phagocytes. The discriminator is the oxidative burst test. In chronic granulomatous disease the burst fails. In IL 12 receptor deficiency the burst is normal because the neutrophil machinery is intact, and what is missing is the signal telling the macrophage to switch on.A missing enzyme and a missing instruction produce similar infections and completely different laboratory results. |
A cytokine is a small secreted protein that one cell uses to change the behaviour of another cell. That is the entire definition. Everything else is detailed about who sends it and who receives it.
An interleukin is simply a cytokine that was named in the series IL 1, IL 2, IL 3 and so on, mostly because it was first described as a signal passing between leukocytes. The numbering reflects the order of discovery and nothing else, which is precisely why memorising by number fails and memorising by function works.
The immune system has no central nervous system. A macrophage at the site of infection cannot see the lymph node and the lymph node cannot see the wound. Coordination has to be chemical, and it has to be local. Cytokines are that chemistry.
You do not need to memorise the family classification, but recognising the names prevents confusion when a question uses one.
Most cytokine receptors have no enzymatic activity of their own. They borrow it, and the enzyme they borrow is a Janus kinase. Understanding this one pathway explains an immunodeficiency, a drug class and a set of shared receptor subunits.
Figure 1. The JAK STAT pathway. One shared mechanism explains X linked SCID and the entire JAK inhibitor drug class.
| CLINICAL PEARL · Two facts worth the whole diagram The common gamma chain is a shared subunit of the receptors for IL 2, IL 4, IL 7, IL 9, IL 15 and IL 21. A mutation in it disables six cytokine signals at once, which is why X linked severe combined immunodeficiency is so profound. IL 7 signalling failure is the reason T cells never develop. JAK inhibitors such as tofacitinib, baricitinib and upadacitinib work one step downstream of the receptor, so a single small molecule damps many cytokines simultaneously. That breadth is also why they carry infection and thrombosis warnings. |
Before any memory work, you need the shape of the system. Every cytokine question is one row of the figure below: a source cell releases a molecule, it reaches a target, and something clinical happens.
Figure 2. Source, cytokine, target and effect. Learn the row and the individual facts come with it.
| MINI SUMMARY · The three tier method we teach Tier one. Hot T Bone stEAK gives you IL 1 through IL 6. This is the foundation and it takes ten minutes. Tier two. Add the four reflex answers. Neutrophils means IL 8. Eosinophils means IL 5. Th1 means IL 12. Calm down means IL 10. Tier three. Attach every cytokine to its T helper subset and its biologic drug. This is where the marks actually are, because tier one facts are also known by every other candidate. |
What follows is the reference core of the guide. Each cytokine is presented the same way so the pattern becomes predictable: where it comes from, what it does, where it shows up clinically, which drug touches it, and how to hold it in memory.
| MEMORY BOX · Original mnemonic IL 1 is the One that turns up the heat. One thermostat, one degree at a time.And for the drug: AnaKINRA KILLS the ONE. |
| MEMORY BOX · Original mnemonic Two Ts. IL 2 is for T cells, and the number 2 contains the same shape you draw when you write a T.Layer the drug on: Basiliximab Blocks the receptor. Ciclosporin Cuts the transcript. |
| MEMORY BOX · Original mnemonicIL 4 opens the allergy door. Four walls, one door, and behind it is IgE.Pair it permanently with its partner: 4 and 13 travel together, which is why one drug blocks both. |
| MEMORY BOX · Original mnemonicIL 5 gives the High Five to Eosinophils. Five fingers, five letters in EOSIN.The classic mnemonic only gives you IgA for IL 5. Eosinophils are the more commonly tested half, so add them deliberately. |
Anemia of chronic disease, iron studies and CAR-T cytokine release syndrome sit in our Hematology-Oncology Crash Course, taught as one connected story.
| MEMORY BOX · Original mnemonicIL 6 makes you feel SICKS. Fever, high CRP, low iron, feeling unwell.The hepcidin link is worth its own line: IL 6 raises hepcidin, hepcidin traps iron, and that is anaemia of chronic disease. |
| MEMORY BOX · Original mnemonicIL 8 puts out the call and neutrophils fill the hall. The classic version is “clean up on aisle 8”, which works, but the recruitment idea is what the questions test.Keep IL 8 and IL 17 side by side in memory, because both bring neutrophils. IL 8 does it in acute infection. IL 17 does it at the barrier surfaces. |
| MEMORY BOX · Original mnemonic TEN Turns Everything Notch down. IL 10 and TGF beta are the two brakes, and they are almost always offered together in the answer options. |
| MEMORY BOX · Original mnemonic Twelve contains a One, and IL 12 makes Th1. The number literally holds the answer.Extend it: IL 12 makes Th1, Th1 makes IFN gamma, IFN gamma makes the macrophage work. Three arrows, one chain. |
| MEMORY BOX · Original mnemonic Seventeen Severs the Skin. Psoriasis, plus neutrophils at the surface.Remember the deficiency direction too: too much IL 17 gives psoriasis, too little gives candida. |
| MEMORY BOX · Original mnemonic for the twenties At 21 the B cell comes of age. IL 21 matures B cells in the germinal centre.22 builds the wall twice. Two twos, two layers of barrier.23 feeds 17. IL 23 keeps Th17 alive, which is why blocking IL 23 treats psoriasis just as blocking IL 17 does. |
| MEMORY BOX · Original mnemonic TNF holds the granuloma together. Cut the wire and tuberculosis walks out.For the drug distinction: the mabs are antibodies, etaNERCEPT is a receptor. Etanercept is notably less effective in granulomatous bowel disease, which is a favourite discriminator. |
| MEMORY BOX · Original mnemonic Gamma is the ignition key. The macrophage is a car with the engine off until IFN gamma turns it.Do not confuse the interferons: alpha and beta fight viruses, gamma fights what lives inside the macrophage. |
Cytokines only make sense once you know which cell released them. The T helper subsets are the organising principle of the whole topic, and once you have this tree the individual interleukins stop being loose facts.
Figure 3. One naive CD4 cell and four destinations. The cytokine in the environment decides which.
Compare the four subsets across the same rows and the differences become almost impossible to confuse.
| Feature | Th1 | Th2 | Th17 | Treg |
|---|---|---|---|---|
| Driven by | IL 12 | IL 4 | IL 6 plus TGF beta | TGF beta plus IL 2 |
| Maintained by | IFN gamma | IL 4 | IL 23 | IL 2 |
| Master transcription factor | T bet | GATA3 | ROR gamma t | FOXP3 |
| Secretes | IFN gamma, IL 2 | IL 4, IL 5, IL 13 | IL 17, IL 22 | IL 10, TGF beta |
| Main effector cell | Macrophage | Eosinophil, mast cell, B cell | Neutrophil, epithelium | All immune cells |
| Fights | Intracellular bacteria, viruses, mycobacteria | Helminths and parasites | Extracellular bacteria and fungi | Nothing, it restrains |
| Antibody effect | IgG opsonising subclasses | IgE and IgA | Minor | Promotes IgA |
| Classic disease | Tuberculosis, sarcoidosis, type 1 diabetes | Asthma, atopy, allergic rhinitis | Psoriasis, IBD, ankylosing spondylitis | IPEX when it fails |
| Inhibited by | IL 4 and IL 10 | IFN gamma | IL 10 | Nothing directly |
| Druggable at | None routinely | Dupilumab, mepolizumab | Secukinumab, ustekinumab | None routinely |
| EXAM TRAP · The cross inhibition point students miss Th1 and Th2 actively suppress each other. IFN gamma from Th1 inhibits Th2, and IL 4 and IL 10 from Th2 inhibit Th1. This is why the immune response tends to commit to one arm rather than run both. It also explains the lepromatous and tuberculoid poles of leprosy. A strong Th1 response gives tuberculoid disease with few organisms and prominent granulomas. A Th2 dominant response gives lepromatous disease with abundant organisms and poor granuloma formation. If a question offers you those two poles, it is really asking about Th1 versus Th2. |
Follicular helper T cells sit in the germinal centre and are defined by CXCR5 expression and IL 21 secretion. They provide the help that B cells need to undergo somatic hypermutation, affinity maturation and class switching. If a question describes a failure of germinal centre formation or a defect in class switching with normal T cell counts, Tfh biology is the underlying subject.
This is the mnemonic almost every student meets first, and it is genuinely useful. It is also incomplete in ways that matter, so we teach it and then immediately teach its gaps.
Figure 4. Every letter decoded. The mnemonic covers IL 1 through IL 6 and stops there.
| MEMORY BOX · The IMGHH extension: Hot T Bone stEAK, then EIGHT TEN TWELVE Keep the original for IL 1 through IL 6, then say this second line immediately after it, every time: “EIGHT calls the neutrophils, TEN calms it all down, TWELVE builds the Th1 crown.” Then finish with the barrier trio:“SEVENTEEN severs the skin, TWENTY TWO builds the wall, TWENTY THREE keeps SEVENTEEN alive.” Three lines total. Recited end to end they carry every interleukin on the examination. |
A mnemonic gives you a list. A memory system gives you retrieval under pressure, which is a different skill. What follows is the system we actually use with students, built in four layers.
Picture a television newsroom during a breaking story. Walk it in the same order every time and the cytokines arrive with the rooms.
Several interleukin numbers contain their own answer. Point this out to yourself once and it never needs revising again.
Assign one colour to each arm and use it in every diagram you draw from now on. Consistency matters more than which colours you choose.
This is the part most students skip, and it is the part that produces exam speed.
| HOW WE TEACH THIS · How we sequence this in a UIT session We do not teach the list and then the diseases. We teach the list, then immediately run a live question set where every stem is a disease and every answer is a cytokine. Students who learn the list alone can recite it in the session and cannot use it a week later. Students who learn it through retrieval keep it, because retrieval practice is what builds durable memory rather than familiarity. |
Six flowcharts cover almost every mechanism a question can ask you to trace. Each is written so it can be reproduced on scrap paper in under thirty seconds.
| Pathogen enters tissue | v Macrophage and dendritic cell recognise it | +=====> IL 1, IL 6, TNF alpha ====> fever, acute phase reactants | +=====> IL 8 ====> neutrophils arrive within hours | v Dendritic cell migrates to the lymph node | v Antigen presented on MHC class II to naive CD4 T cell | +=====> IL 12 present ====> Th1 +=====> IL 4 present ====> Th2 +=====> IL 6 + TGF beta ===> Th17 +=====> TGF beta alone ====> Treg |
| Th1 cell | +=====> IFN gamma =====> Macrophage | | | +==> phagolysosome fusion increases | +==> reactive oxygen species increase | +==> MHC class II expression increases | +==> TNF alpha released v CD40 ligand binds CD40 on the macrophage (second required signal) RESULT: the macrophage can now kill what is living inside it |
| B cell in the germinal centre | Tfh cell provides CD40L and IL 21 | +===> IL 4 =====> IgE and IgG +===> IL 5 =====> IgA +===> TGF beta ==> IgA +===> IFN gamma => IgG opsonising subclasses | v Somatic hypermutation and affinity maturation | v Plasma cell or memory B cell |
| IL 1 and TNF alpha act on endothelium | v Selectins appear ====> neutrophil ROLLING | v IL 8 activates integrins ====> TIGHT ADHESION | v PECAM 1 at the junction ====> TRANSMIGRATION | v IL 8 gradient ====> CHEMOTAXIS to the organism Fail at adhesion = leukocyte adhesion deficiency type 1 (CD18) Fail at chemotaxis = Chediak Higashi syndrome |
Figure 5. IFN gamma builds the granuloma and TNF alpha holds it together. Blocking TNF alpha is why latent tuberculosis reactivates.
Figure 6. Six steps from bacterial entry to fever, each one a named molecule.
| MACROPHAGE / | \ IL 1, IL 6, IL 8 IL 12 TNF alpha | | | v v fever and neutrophil NAIVE CD4 T CELL acute phase chemotaxis | +==========+==========+==========+ | | | | Th1 Th2 Th17 Treg | | | | IFN gamma IL 4, 5, 13 IL 17, 22 IL 10 IL 2 TGF beta | | | | v v v v macrophage eosinophil neutrophil everything activation and IgE at barrier switched off |
| FEVER GROUP IL 1 IL 6 TNF alpha RECRUITERS IL 8 (neutrophil) IL 5 (eosinophil) T CELL GROWTH IL 2 MARROW GROUP IL 3 IL 7 IL 11 G CSF GM CSF ANTIBODY SWITCHING IL 4 (IgE) IL 5 (IgA) TGF beta (IgA) IL 21 (all) TH1 AXIS IL 12 ==> IFN gamma TH17 AXIS IL 6 + TGF beta ==> IL 17, IL 22 maintained by IL 23 BRAKES IL 10 TGF beta Eight groups. Learn the group, then place the number inside it. |
Biologic drugs are the single easiest source of marks in this topic, because each one announces its own target. If you know what the drug blocks, you know the pathway, the indication and the adverse effect profile.
Figure 7. Each biologic cuts one named wire in the cytokine network.
The table below adds the detail the figure cannot carry, including the adverse effect that examiners return to most often.
| Drug | Target | Mechanism | Main indications | USMLE pearl |
|---|---|---|---|---|
| Infliximab, adalimumab | TNF alpha | Monoclonal antibody neutralises TNF alpha | Rheumatoid arthritis, Crohn disease, ulcerative colitis, psoriasis | Screen for latent tuberculosis before starting. Granuloma breakdown causes reactivation |
| Etanercept | TNF alpha | Decoy receptor fused to an IgG Fc fragment | Rheumatoid arthritis, psoriasis, ankylosing spondylitis | Notably less effective in Crohn disease than the antibodies, which is a favourite discriminator |
| Anakinra | IL 1 receptor | Recombinant receptor antagonist | Rheumatoid arthritis, Still disease, CAPS | Short half life, given daily |
| Canakinumab | IL 1 beta | Monoclonal antibody | CAPS, periodic fever syndromes, gout | Long acting alternative to anakinra |
| Tocilizumab, sarilumab | IL 6 receptor | Blocks receptor signalling | Rheumatoid arthritis, giant cell arteritis, cytokine release syndrome | Lowers CRP, so CRP can no longer be used to detect infection |
| Ustekinumab | IL 12 and IL 23 p40 | Binds the shared p40 subunit | Psoriasis, psoriatic arthritis, Crohn disease | One antibody, two cytokines, because of the shared subunit |
| Secukinumab, ixekizumab | IL 17A | Monoclonal antibody | Psoriasis, ankylosing spondylitis, psoriatic arthritis | Can worsen inflammatory bowel disease, because IL 17 protects the gut barrier |
| Dupilumab | IL 4 receptor alpha | Blocks IL 4 and IL 13 together | Atopic dermatitis, asthma, nasal polyposis | Conjunctivitis is the characteristic adverse effect |
| Mepolizumab, benralizumab | IL 5 or its receptor | Depletes eosinophils | Eosinophilic asthma, EGPA | Watch for the eosinophil count falling to zero |
| Basiliximab | IL 2 receptor alpha (CD25) | Blocks T cell expansion | Transplant induction | Used at induction, not for maintenance |
| Aldesleukin | IL 2 agonist | Recombinant IL 2 | Renal cell carcinoma, melanoma | Causes capillary leak syndrome |
| Tofacitinib | JAK | Small molecule inhibiting downstream signalling | Rheumatoid arthritis, ulcerative colitis | Blocks many cytokines at once, so infection and thrombosis risk rise |
| Filgrastim | G CSF agonist | Recombinant colony stimulating factor | Chemotherapy induced neutropenia | Bone pain is the classic adverse effect |
| MEMORY BOX · Original drug mnemonic “AnaKINRA kills ONE. TociliZUMAB takes SIX. UsteKINUMAB unites TWELVE and TWENTY THREE. SecuKINUMAB severs SEVENTEEN. DupiLUMAB doubles up on FOUR and THIRTEEN.” Then attach the single most tested safety fact: any TNF blocker requires latent tuberculosis screening first. |
Disseminated BCG, TB on a biologic, the two poles of leprosy. Our Microbiology Crash Course teaches the organisms alongside the immune arm that fails.
A cytokine question is almost never labelled as a cytokine question. It arrives as a disease. This table runs the translation in the direction the examination actually uses.
| Disease | Dominant arm | Key cytokines | What the stem will say |
|---|---|---|---|
| Tuberculosis | Th1 | IL 12, IFN gamma, TNF alpha | Caseating granuloma, or reactivation on a biologic |
| Sarcoidosis | Th1 | IFN gamma, TNF alpha | Non caseating granulomas, hypercalcaemia, raised ACE |
| Lepromatous leprosy | Th2 dominant | IL 4, IL 10 | Abundant organisms, poor granuloma formation |
| Asthma and atopy | Th2 | IL 4, IL 5, IL 13 | Eosinophilia, raised IgE, mucus plugging |
| Helminth infection | Th2 | IL 4, IL 5 | Eosinophilia with travel or exposure history |
| Psoriasis | Th17 | IL 17, IL 22, IL 23 | Silvery plaques improving on a biologic |
| Inflammatory bowel disease | Th1 and Th17 | TNF alpha, IL 12, IL 23 | Response to infliximab or ustekinumab |
| Rheumatoid arthritis | Th1 and Th17 | TNF alpha, IL 1, IL 6, IL 17 | Symmetric small joint arthritis with raised CRP |
| Cytokine release syndrome | Innate | IL 6, TNF alpha | Fever and hypotension days after CAR T therapy |
| Septic shock | Innate | TNF alpha, IL 1, IL 6 | Vasodilation, capillary leak, disseminated coagulation |
| Anaemia of chronic disease | Innate | IL 6 raising hepcidin | Low serum iron, low transferrin, raised ferritin |
| HIV | Progressive Th1 loss | Falling IL 2 and IFN gamma | Opportunistic intracellular infections as CD4 count falls |
| Chronic granulomatous disease | Normal cytokines | IFN gamma given as therapy | Failed oxidative burst with catalase positive organisms |
| IL 12 receptor deficiency | Absent Th1 | Low IFN gamma | Disseminated infection after BCG vaccination |
The HIV row deserves its own study. We go through how falling CD4 counts change which organisms appear, which is the Th1 axis failing in slow motion.
| CLINICAL PEARL · The single most useful integration in this guide Take the chain IL 12 to Th1 to IFN gamma to activated macrophage and notice how many diseases sit along it. IL 12 receptor deficiency breaks it at the start. HIV breaks it in the middle by removing CD4 cells. Chronic granulomatous disease breaks it at the end, inside the macrophage. TNF inhibitors break the granuloma the chain builds. Four very different conditions, one pathway. This is what integrated study means in practice and it is why we refuse to teach cytokines as a standalone list. |
The question writers reuse a small set of framings. Each row below is a stem pattern we have seen repeatedly, paired with what it is actually testing. Learn the left column and your reading time on these items halves.
| If the stem says | It is testing | Answer with |
|---|---|---|
| Fever with a raised CRP | Acute phase response | IL 1, IL 6 and TNF alpha |
| Neutrophils arriving at an abscess | Chemotaxis | IL 8 |
| A raised eosinophil count | Th2 recruitment | IL 5 |
| Raised serum IgE | Class switching | IL 4 |
| Class switching to IgA | Mucosal antibody | IL 5 and TGF beta |
| A T cell that will not proliferate | Growth signal | IL 2 |
| Disseminated infection after BCG | Th1 axis failure | IL 12 receptor deficiency with low IFN gamma |
| A macrophage that cannot kill what it engulfed | Macrophage activation | IFN gamma |
| Tuberculosis reactivating on a biologic | Granuloma maintenance | TNF alpha inhibition |
| Psoriasis improving on a monoclonal antibody | Th17 axis | IL 17 or IL 23 blockade |
| Persistent candida on skin and mucosa | Th17 deficiency | Impaired IL 17 signalling |
| Fever and hypotension after CAR T therapy | Cytokine release syndrome | IL 6, treat with tocilizumab |
| Low serum iron with a raised ferritin | Hepcidin | IL 6 |
| A cytokine that reduces MHC class II expression | Immune suppression | IL 10 |
| Severe combined immunodeficiency in a male infant | Shared receptor subunit | Common gamma chain mutation |
| A drug that lowers CRP so infection is masked | IL 6 blockade | Tocilizumab |
| Capillary leak after immunotherapy | IL 2 toxicity | Aldesleukin |
| Bone pain after chemotherapy support | Marrow stimulation | Filgrastim, a G CSF agonist |
| Very early onset colitis in an infant | Loss of the brake | IL 10 pathway defect |
| A biologic that treats psoriasis but worsens colitis | Barrier protection | IL 17 blockade |
| Abundant organisms with poor granulomas in leprosy | Th2 dominance | IL 4 and IL 10 |
| Few organisms with strong granulomas in leprosy | Th1 dominance | IFN gamma |
| A cytokine that inhibits Th2 differentiation | Cross regulation | IFN gamma |
| A cytokine that inhibits Th1 differentiation | Cross regulation | IL 4 and IL 10 |
| One antibody blocking two cytokines | Shared subunit | Ustekinumab on p40, or dupilumab on IL 4 receptor alpha |
One hundred single line facts. Read them as a checklist rather than as prose, and mark any line you could not have produced yourself.
Print the page below, keep it in the front of your folder, and read it the night before the examination. It is deliberately compressed to fit on a single sheet.
Figure 8. The entire topic on one page. If you can reproduce this from memory you are finished with cytokines.
These are the questions students actually type into a search bar the week before an examination. Each answer is written to stand alone, so you can read any one of them without having read the rest of this guide.
Cytokines are small secreted proteins that one cell uses to change the behaviour of another cell. They are the chemical language of the immune system, because a macrophage in a wound and a lymph node several centimetres away have no other way to coordinate.
All interleukins are cytokines. Interleukin is simply the naming series used for cytokines first described as signals passing between leukocytes. Interferons, tumour necrosis factors, chemokines and colony stimulating factors are cytokines with different names.
Use three layers. Start with Hot T Bone stEAK for IL 1 through IL 6. Add the four reflex answers, which are IL 8 for neutrophils, IL 5 for eosinophils, IL 12 for Th1 and IL 10 for switching the response off. Then attach each cytokine to its T helper subset and its biologic drug. Learning by function beats learning by number, because the numbers carry no meaning.
Hot is IL 1 causing fever. T is IL 2 stimulating T cells. Bone is IL 3 supporting bone marrow. E is IL 4 driving class switching to IgE. A is IL 5 driving class switching to IgA. K stands for aKute phase reactants induced by IL 6.
It omits eosinophils under IL 5, which is the more commonly tested function, and it omits the Th2 driving role of IL 4. It also stops at IL 6, so IL 8, IL 10, IL 12, IL 17, IL 21, IL 22 and IL 23 are entirely absent. Those omissions are exactly where the discriminating questions sit.
IL 1, IL 6 and TNF alpha. They raise the hypothalamic set point through prostaglandin E2. IL 1 is described as the prototypical endogenous pyrogen.
IL 8, also called CXCL8, is the major neutrophil chemotactic factor in acute infection. IL 17 also recruits neutrophils, but specifically to epithelial barrier surfaces.
IL 5. If a stem mentions a raised eosinophil count anywhere, IL 5 is almost always the intended answer. It is also the target of mepolizumab and benralizumab.
IFN gamma is the answer. It increases phagolysosome fusion and reactive oxygen production and raises MHC expression. The CD40 to CD40 ligand interaction provides a necessary second signal.
IL 6 is the principal driver, supported by IL 1 and TNF alpha. The acute phase reactants induced include CRP, fibrinogen, ferritin, hepcidin and serum amyloid A.
Ten questions in the current single best answer format. Commit to an answer before reading the explanation, and do not skip the wrong answer analysis, because that is where most of the learning is.
Difficulty: Moderate | Competency tested: Mechanisms of disease, immune system
A 10 month old boy develops a disseminated infection after routine BCG vaccination. He later has an episode of non typhoidal Salmonella bacteraemia. Neutrophil count, immunoglobulin levels and the dihydrorhodamine oxidative burst test are all normal. His parents are first cousins. Serum interferon gamma is low. Which of the following is the most likely underlying defect?
(A) NADPH oxidase deficiency
(B) IL 12 receptor deficiency
(C) Common gamma chain mutation
(D) Bruton tyrosine kinase deficiency
(E) LFA 1 integrin deficiency
| QUICK ANSWER · Correct answer: B. IL 12 receptor deficiency Control of mycobacteria and intracellular Salmonella requires macrophages activated by IFN gamma, which comes from Th1 cells, which are created by IL 12. A defect in IL 12 signalling prevents Th1 differentiation, so IFN gamma is low and macrophages are never switched on. Consanguinity fits the autosomal recessive inheritance, and the normal oxidative burst confirms that the macrophage killing machinery itself is intact. |
Why the other options are wrong
| MEMORY BOX · High yield pearl IL 12 makes Th1, Th1 makes IFN gamma, IFN gamma makes the macrophage work. Break the chain anywhere and mycobacteria disseminate. |
Difficulty: Easy to moderate | Competency tested: Pharmacotherapy
A 46 year old woman with rheumatoid arthritis is due to start infliximab. Which of the following must be completed before the first dose?
(A) Baseline pulmonary function testing
(B) Screening for latent tuberculosis
(C) Measurement of serum IgE
(D) Ophthalmological examination
(E) Bone mineral density scan
| QUICK ANSWER · Correct answer: B. Screening for latent tuberculosis TNF alpha maintains the structural integrity of granulomas. Infliximab neutralises TNF alpha, allowing established granulomas to break down and release contained mycobacteria. Latent tuberculosis therefore reactivates, sometimes with disseminated or extrapulmonary disease. Screening with an interferon gamma release assay or tuberculin skin test, plus a chest radiograph, is mandatory before treatment. |
Why the other options are wrong
| MEMORY BOX · High yield pearl Any TNF alpha inhibitor requires latent tuberculosis screening first. This is among the most reliably tested facts in immunology. |
Difficulty: Moderate | Competency tested: Mechanisms of disease
A 27 year old man with severe eosinophilic asthma has a blood eosinophil count of 850 per microlitre despite maximal inhaled therapy. He is started on a monoclonal antibody, and his eosinophil count falls to near zero with marked symptomatic improvement. Which cytokine does this drug most likely target?
(A) IL 4
(B) IL 5
(C) IL 8
(D) IL 12
(E) TNF alpha
| QUICK ANSWER · Correct answer: B. IL 5 IL 5 is the principal cytokine driving eosinophil growth, differentiation, recruitment and survival. Mepolizumab and reslizumab bind IL 5 directly, while benralizumab binds the IL 5 receptor alpha chain and depletes eosinophils more completely. A near total fall in the eosinophil count after starting a biologic points specifically to this axis. |
Why the other options are wrong
| MEMORY BOX · High yield pearl Any eosinophil count in a stem should make you think IL 5 before you read the options. |
Difficulty: Moderate to hard | Competency tested: Mechanisms of disease, haematology
A 62 year old man with long standing rheumatoid arthritis is found to have a haemoglobin of 10.1 g/dL, a low serum iron, a low total iron binding capacity and a raised ferritin. Which cytokine best explains this pattern?
(A) IL 2
(B) IL 5
(C) IL 6
(D) IL 10
(E) IFN gamma
| QUICK ANSWER · Correct answer: C. IL 6 This is anaemia of chronic disease. IL 6 stimulates hepatic production of hepcidin, which degrades ferroportin and therefore traps iron inside macrophages and blocks intestinal absorption. The result is a low serum iron with a raised ferritin, because total body iron stores are adequate but unavailable. A low total iron binding capacity distinguishes this from true iron deficiency, where it is raised. |
Why the other options are wrong
| MEMORY BOX · High yield pearl IL 6 raises hepcidin and hepcidin traps iron. Low serum iron with a raised ferritin is the fingerprint. |
Difficulty: Moderate | Competency tested: Mechanisms of disease, immunology
A researcher culturing naive CD4 T cells adds a single recombinant cytokine to the medium. After several days the cells express ROR gamma t and secrete IL 17 and IL 22. Which cytokine combination was most likely added?
(A) IL 12 alone
(B) IL 4 alone
(C) IL 6 with TGF beta
(D) IFN gamma with IL 2
(E) IL 10 with TGF beta
| QUICK ANSWER · Correct answer: C. IL 6 with TGF beta ROR gamma t is the master transcription factor of Th17 cells, and IL 17 and IL 22 are their signature products. Th17 differentiation requires IL 6 acting together with TGF beta. IL 23 is important afterwards, maintaining the population once it has formed, but it does not create Th17 cells from naive precursors. |
Why the other options are wrong
| MEMORY BOX · High yield pearl TGF beta alone gives Treg. Add IL 6 and the same cell becomes Th17. One cytokine flips tolerance into inflammation. |
Difficulty: Moderate | Competency tested: Pharmacotherapy, mechanisms of disease
A 23 year old man receives CAR T cell therapy for refractory B cell lymphoma. Four days later he develops fever of 39.4 degrees Celsius, hypotension and hypoxia. Ferritin and CRP are markedly raised. Blood cultures are negative. Which agent most directly targets the cytokine driving this syndrome?
(A) Anakinra
(B) Tocilizumab
(C) Etanercept
(D) Ustekinumab
(E) Filgrastim
| QUICK ANSWER · Correct answer: B. Tocilizumab This is cytokine release syndrome, in which activated CAR T cells and bystander macrophages release large quantities of IL 6. IL 6 drives the fever, the acute phase response and the vascular changes producing hypotension and hypoxia. Tocilizumab blocks the IL 6 receptor and is the established first line treatment, with glucocorticoids added for severe or refractory cases. |
Why the other options are wrong
| MEMORY BOX · High yield pearl Fever and hypotension days after CAR T therapy equals IL 6. The answer is tocilizumab. |
Difficulty: Hard | Competency tested: Mechanisms of disease, integration
A 34 year old woman with plaque psoriasis begins a biologic and her skin clears substantially. Six months later she develops bloody diarrhoea, abdominal pain and weight loss, and colonoscopy shows patchy inflammation with ulceration. Which drug mechanism most likely explains this sequence?
(A) IL 17A blockade
(B) TNF alpha blockade
(C) IL 5 blockade
(D) IL 2 receptor blockade
(E) IL 1 receptor antagonism
| QUICK ANSWER · Correct answer: A. IL 17A blockade IL 17 recruits neutrophils and induces antimicrobial peptides at epithelial surfaces, and it plays a protective role in maintaining the intestinal barrier. Blocking IL 17A clears psoriatic skin very effectively but removes that mucosal protection, and new onset or worsening inflammatory bowel disease is a recognised adverse effect of secukinumab, ixekizumab and brodalumab. |
Why the other options are wrong
| MEMORY BOX · High yield pearl IL 17 blockade clears skin and can unmask bowel disease, because IL 17 guards the gut barrier as well as the skin. |
Difficulty: Moderate | Competency tested: Mechanisms of disease, immunology
A 4 month old boy has persistent oral thrush, chronic diarrhoea and Pneumocystis jirovecii pneumonia. Lymphocyte count is markedly reduced and the thymic shadow is absent on chest radiograph. Sequencing shows a mutation in a receptor subunit shared by several cytokines. Which cytokine is most responsible for the failure of T cell development in this child?
(A) IL 2
(B) IL 4
(C) IL 7
(D) IL 15
(E) IL 21
| QUICK ANSWER · Correct answer: C. IL 7 This is X linked severe combined immunodeficiency caused by a common gamma chain mutation. That subunit is shared by the receptors for IL 2, IL 4, IL 7, IL 9, IL 15 and IL 21. Of these, IL 7 is the cytokine essential for the survival and expansion of early lymphoid progenitors in the thymus and marrow, so its loss is the reason T cells never develop and the thymic shadow is absent. |
Why the other options are wrong
| MEMORY BOX · High yield pearl The common gamma chain serves six cytokines, but IL 7 is the one that explains the missing T cells. |
Difficulty: Moderate to hard | Competency tested: Mechanisms of disease, microbiology integration
A patient with leprosy has widespread nodular skin lesions, loss of eyebrows and a skin biopsy showing abundant acid fast bacilli within foamy macrophages, with very few lymphocytes and no organised granulomas. Which cytokine profile best explains this presentation?
(A) High IFN gamma with low IL 4
(B) High IL 4 and IL 10 with low IFN gamma
(C) High IL 8 with low IL 17
(D) High IL 5 with low IL 2
(E) High TGF beta with high IFN gamma
| QUICK ANSWER · Correct answer: B. High IL 4 and IL 10 with low IFN gamma This is lepromatous leprosy, which reflects a Th2 dominant response. IL 4 and IL 10 suppress Th1 differentiation and reduce IFN gamma, so macrophages are never properly activated. Without macrophage activation the organisms multiply freely inside foamy macrophages and no organised granuloma forms. The opposite pole, tuberculoid leprosy, shows a strong Th1 response with high IFN gamma, few organisms and well formed granulomas. |
Why the other options are wrong
| MEMORY BOX · High yield pearl The two poles of leprosy are a clean natural experiment in Th1 versus Th2. Organisms abundant means Th2, granulomas prominent means Th1. |
Difficulty: Hard | Competency tested: Pharmacotherapy, clinical reasoning
A 58 year old woman taking tocilizumab for rheumatoid arthritis presents with three days of cough and pleuritic chest pain. She is afebrile. CRP is 4 mg/L and the white cell count is normal. Chest radiograph shows a right lower lobe consolidation. Which of the following best explains the discrepancy between her laboratory results and her radiograph?
(A) The consolidation represents a rheumatoid nodule rather than infection
(B) Blockade of the IL 6 receptor suppresses hepatic CRP production
(C) Tocilizumab causes a false reduction in the measured white cell count
(D) The infection is too early to raise inflammatory markers
(E) Rheumatoid arthritis itself suppresses the acute phase response
| QUICK ANSWER · Correct answer: B. Blockade of the IL 6 receptor suppresses hepatic CRP production CRP is synthesised by hepatocytes in direct response to IL 6. Tocilizumab blocks the IL 6 receptor, so the liver never receives the signal and CRP remains low regardless of how severe the underlying infection is. Fever is often blunted for the same reason. Clinicians managing patients on IL 6 blockade must therefore rely on clinical assessment and imaging rather than inflammatory markers, and this is a recognised safety concern with the drug class. |
Why the other options are wrong
| MEMORY BOX · High yield pearl On tocilizumab, a normal CRP does not exclude infection. Blocking the signal removes the marker, not the disease. |
Book a free call with mentors who passed Step 1 as IMGs. We’ll map the same structure-first approach across your remaining subjects and your real timeline.
Recall the 14 month old with disseminated Mycobacterium avium infection after BCG vaccination. Run the three step method. Arm: the organisms are intracellular, so this is the Th1 axis. Cell: the macrophage is the effector that has failed. Molecule: the macrophage is activated by IFN gamma, which comes from Th1 cells, which are created by IL 12. The answer is IL 12 receptor deficiency with a low IFN gamma.
Management follows directly from the mechanism. Avoid all live vaccines including BCG. Treat active mycobacterial infection with prolonged combination therapy. Recombinant IFN gamma can be given to bypass the missing signal. Screen siblings, since the inheritance is autosomal recessive, and counsel the family about prompt assessment of any febrile illness.
| HOW WE TEACH THIS · What this case teaches about studying You did not need to recall a list of immunodeficiencies. You needed one chain, IL 12 to Th1 to IFN gamma to macrophage, and the ability to ask where it broke. That is what mechanistic study produces and what pure memorisation cannot.This is why the Ultimate Integrated Teaching approach places cytokines early and then reuses them across microbiology, pathology and pharmacology rather than treating them as a standalone immunology list. |
Sources used to verify factual content. Editions and guidelines change, so verify against the current edition before relying on any specific detail.
If the interleukins feel smaller than they did an hour ago, that was the intention. Forty molecules with arbitrary numbers is an impossible memorisation task. Three mnemonic lines, four T helper subsets and one drug list is not.
We build every USMLE Impact Theory program on that principle. Find the structure first, attach the facts to it, then use the structure across four or five other subjects in the same sitting. It feels slower on day one but it is considerably faster by week three. If you are still deciding how to sequence your subjects, our Step 1 study plan for IMGs lays out 3, 6 and 12 month versions. If you are rebuilding after a failed attempt, start there instead.
Articles published by IMG Helping Hands are prepared by our team using information from direct experience, publicly available resources, and educational references. AI tools may be used to assist with drafting, proofreading, and formatting; however, all content undergoes review and approval before publication.
The information provided is intended for educational purposes only. Requirements, policies, and processes may change over time. Readers should consult official sources for the most current information.
Get our most valuable tips right inside your inbox, once per month!
